Anti-HER2 SNIPR T cells were cocultured with the HER2+ breast cancer line SKBR3 and the HER2– breast cancer line MD468 for 48 h to induce SNIPR activation and downstream reporter gene expression (Supplemental Fig. 4C). Here, ERBB2 is linked to breast carcinoma.